21
edits
Difference between revisions of "Prostate cancer"
Jump to navigation
Jump to search
→Situations where prostate adenocarcinoma may be missed{{cite journal |vauthors=Yang C, Humphrey PA |title=False-Negative Histopathologic Diagnosis of Prostatic Adenocarcinoma |journal=Arch. Pathol. Lab. Med. |volume=144 |issue=3 |pages=326–334 |date=March 2020 |pmid=31729886 |doi=10.5858/arpa.2019-0456-RA |url=}}
| Line 241: | Line 241: | ||
Memory device: '''AAABBRS''' = atrophy, adenosis, adenosis (sclerosing), basal cell hyperplasia, bulbourethral gland, radiation, seminal vesicles. | Memory device: '''AAABBRS''' = atrophy, adenosis, adenosis (sclerosing), basal cell hyperplasia, bulbourethral gland, radiation, seminal vesicles. | ||
===Situations where prostate adenocarcinoma may be missed{{cite journal |vauthors=Yang C, Humphrey PA |title=False-Negative Histopathologic Diagnosis of Prostatic Adenocarcinoma |journal=Arch. Pathol. Lab. Med. |volume=144 |issue=3 |pages=326–334 |date=March 2020 |pmid=31729886 |doi=10.5858/arpa.2019-0456-RA |url=}}=== | ===Situations where prostate adenocarcinoma may be missed<ref>{{cite journal |vauthors=Yang C, Humphrey PA |title=False-Negative Histopathologic Diagnosis of Prostatic Adenocarcinoma |journal=Arch. Pathol. Lab. Med. |volume=144 |issue=3 |pages=326–334 |date=March 2020 |pmid=31729886 |doi=10.5858/arpa.2019-0456-RA |url=}}</ref>=== | ||
*Tissue artefacts (try levels and/or IHC) | *Tissue artefacts (try levels and/or IHC) | ||
**Crush artefact obscuring architectural or cytologic features | **Crush artefact obscuring architectural or cytologic features | ||